Legal & General Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$792K Buy
84,575
+3,937
+5% +$36.9K ﹤0.01% 2308
2025
Q1
$991K Sell
80,638
-224
-0.3% -$2.75K ﹤0.01% 2189
2024
Q4
$1.07M Sell
80,862
-76
-0.1% -$1K ﹤0.01% 2217
2024
Q3
$1.56M Buy
80,938
+6,513
+9% +$125K ﹤0.01% 2073
2024
Q2
$1.53M Buy
74,425
+4,647
+7% +$95.4K ﹤0.01% 2062
2024
Q1
$1.66M Buy
69,778
+14,656
+27% +$349K ﹤0.01% 2005
2023
Q4
$1.19M Buy
55,122
+4,945
+10% +$107K ﹤0.01% 2152
2023
Q3
$728K Sell
50,177
-510
-1% -$7.4K ﹤0.01% 2297
2023
Q2
$1.06M Buy
50,687
+21,679
+75% +$454K ﹤0.01% 2201
2023
Q1
$613K Buy
29,008
+7,748
+36% +$164K ﹤0.01% 2271
2022
Q4
$541K Buy
21,260
+2,044
+11% +$52K ﹤0.01% 2313
2022
Q3
$462K Buy
19,216
+1,744
+10% +$41.9K ﹤0.01% 2364
2022
Q2
$336K Buy
17,472
+4,107
+31% +$79K ﹤0.01% 2456
2022
Q1
$232K Buy
13,365
+872
+7% +$15.1K ﹤0.01% 2620
2021
Q4
$273K Hold
12,493
﹤0.01% 2593
2021
Q3
$239K Buy
12,493
+7,450
+148% +$143K ﹤0.01% 2629
2021
Q2
$87K Sell
5,043
-492
-9% -$8.49K ﹤0.01% 2784
2021
Q1
$124K Buy
5,535
+1,406
+34% +$31.5K ﹤0.01% 2562
2020
Q4
$92K Buy
4,129
+807
+24% +$18K ﹤0.01% 2609
2020
Q3
$49K Sell
3,322
-1,124
-25% -$16.6K ﹤0.01% 2703
2020
Q2
$66K Buy
4,446
+699
+19% +$10.4K ﹤0.01% 2648
2020
Q1
$41K Sell
3,747
-553
-13% -$6.05K ﹤0.01% 2667
2019
Q4
$38K Buy
4,300
+787
+22% +$6.96K ﹤0.01% 2929
2019
Q3
$26K Hold
3,513
﹤0.01% 3037
2019
Q2
$33K Buy
3,513
+948
+37% +$8.91K ﹤0.01% 2966
2019
Q1
$13K Hold
2,565
﹤0.01% 3209
2018
Q4
$11K Hold
2,565
﹤0.01% 3258
2018
Q3
$21K Hold
2,565
﹤0.01% 3185
2018
Q2
$18K Buy
2,565
+250
+11% +$1.75K ﹤0.01% 3214
2018
Q1
$33K Hold
2,315
﹤0.01% 2947
2017
Q4
$20K Hold
2,315
﹤0.01% 3144
2017
Q3
$27K Buy
2,315
+1,208
+109% +$14.1K ﹤0.01% 3092
2017
Q2
$15K Hold
1,107
﹤0.01% 3260
2017
Q1
$15K Hold
1,107
﹤0.01% 3143
2016
Q4
$8K Buy
+1,107
New +$8K ﹤0.01% 3251